This is Infeeds, an online directory for news, stories and ideas. Share your story with us.
In an era where audiences value authenticity and relevance, content partnerships are emerging as one of the most effective ways for platforms and creators to grow sustainably.
Researchers discovered biological markers that appear in blood during early Parkinson's stages, opening a crucial window for diagnosis before irreversible damage.
A mental health leader's raw account of outsourcing his inner life to algorithms, one exhausted midnight conversation at a time.
Read latest on Infeeds
Fashion designer Jeremy Scott ripped up an AI-written speech at graduation, while other speakers faced boos for discussing artificial intelligence.
New research suggests GLP-1 medications may slow cancer progression. Here's what the data actually shows and why experts say it's too early to celebrate.
Spyware attacks on journalists and activists are now routine. Here's what you need to know about the security features that actually work.
The NASCAR legend died after pneumonia escalated into sepsis. Here's what that means and why it matters.
Tesla's Master Plan promised a solar electric economy. So why is Musk's AI company powering data centers with fossil fuels?
New travel restrictions aim to contain Ebola spread, but public health experts argue screening alone won't stop the outbreak where it actually matters.
After months of delays, the Trump Mobile T1 finally shipped. Here's what we found in the box—and what's already going wrong.
New Cleveland Clinic data suggest GLP-1 medications could slow cancer spread, but experts warn we're nowhere near prescribing them for tumor treatment.
